Insuman Basal 100 for Optipen: Innovative insulin of medium duration of action
Insuman Basal 100 for Optipen is an innovative drug from the group of medium-acting insulins. This product is manufactured in Germany by Hoechst AG and has the international name "Insulin-SrD". It is an injection suspension with a concentration of 100 IU/ml.
Insuman Basal 100 for Optipen is designed to make life easier for people with diabetes, especially for those who prefer to use injection pens such as Optipen. This drug provides a stable reduction in blood glucose levels over a long period of time, which allows patients to effectively control their glycemia.
The main advantage of Insuman Basal 100 for Optipen is its ease of use. The Optipen system provides precise and easy injections, and the insulin suspension allows you to evenly distribute the dose of the drug in the body. This is especially important for patients who require regular insulin injections to maintain normal blood glucose levels.
Insuman Basal 100 for Optipen is available in various dosage forms, allowing patients to choose the option that is most convenient for them. The drug is also known under various synonyms, including “B-Insulin Berlin-Chemie”, “Berlinsulin N Basal U-40”, “Biogulin NPH U-100” and others.
It is important to note that before using Insuman Basal 100 for Optipen, you must consult your doctor and follow his recommendations regarding dosage and regimen. Only a qualified medical specialist will be able to determine the optimal dose and regimen of insulin therapy for each patient, based on his individual needs and body characteristics.
In conclusion, Insuman Basal 100 for Optipen is an innovative intermediate-acting insulin designed to conveniently and effectively control blood glucose levels in patients with diabetes. This drug allows patients to use injection pens, such as Optipen, and provides stable reductions in glucose levels over time. However, you should consult your physician before use to determine the optimal dosage and regimen for best results.